Eco R1 Capital, LLC Cullinan Oncology, Inc. Transaction History

Eco R1 Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$10.2 - $11.91 $8.04 Million - $9.39 Million	-788,628 Reduced 76.19%	246,410 $2.52 Million
Q4 2022 Feb 14, 2023	SELL	$9.72 - $13.62 $1.05 Million - $1.47 Million	-108,180 Reduced 9.46%	1,035,038 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$11.82 - $15.42 $315,251 - $411,266	-26,671 Reduced 2.28%	1,143,218 $14.7 Million
Q2 2022 Aug 15, 2022	BUY	$7.31 - $13.55 $8.55 Million - $15.9 Million	1,169,889 New	1,169,889 $15 Million

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $613M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.